Aggressive cutaneous T-cell lymphomas after TNFalpha blockade

Journal of the American Academy of Dermatology
Amy E AdamsThomas S Kupper

Abstract

Pharmacologic blockade of TNFalpha has been a highly effective approach to treating several immunologically mediated diseases, including rheumatoid arthritis, Crohn's disease, and psoriatic arthritis. 1,2,3 Both etanercept, the recombinant extracellular domain of the tumor necrosis factor receptor 2 (TNFR2), and infliximab, a humanized murine antibody, bind TNFalpha and block its interaction with cell surface receptors. Recently, it has become clear that blockade of TNFalpha action is profoundly immunosuppressive, and may result in reactivation of tuberculosis and histoplasmosis, as well as the emergence of B-cell lymphomas. 4,5,6 In this report, we describe two cases of cutaneous and systemic T-cell lymphoma that progressed rapidly in the setting of TNFalpha blockade. Both cases were characterized by rapid onset, a fulminant clinical course with extensive cutaneous and systemic involvement, and death within months of diagnosis.

References

Sep 1, 1993·Journal of the American Academy of Dermatology·M K Burns, K D Cooper
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·S Y LeeY Choi
Mar 1, 1997·Molecular and Cellular Biology·C S DuckettC B Thompson
Nov 25, 1998·Seminars in Immunology·R Horie, T Watanabe
Dec 10, 1999·The New England Journal of Medicine·C Robert, T S Kupper
Jun 1, 2002·Science·Guoqing Chen, David V Goeddel
May 17, 2003·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Juergen Braun, Joachim Sieper

❮ Previous
Next ❯

Citations

Nov 16, 2011·Biotechnology Letters·Jia ZhanHong Lu
Mar 18, 2008·Lancet·Sam T HwangWyndham H Wilson
Sep 22, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Robert P HasserjianDennis P O'Malley
Jun 16, 2005·Current Opinion in Rheumatology·Philip J Mease
Mar 25, 2008·Therapeutics and Clinical Risk Management·Kim A Papp
Mar 21, 2008·Expert Opinion on Biological Therapy·Erin Ducharme, Jeffrey M Weinberg
Feb 1, 2007·The British Journal of Dermatology·J N DauendorfferH Bachelez
Jan 26, 2011·Journal of Cutaneous Pathology·Begoña VieitesFrancisco Carvajo
Feb 3, 2012·Immunopharmacology and Immunotoxicology·Giampiero GirolomoniGino Antonio Vena
Oct 2, 2012·Dermatologic Clinics·Joshua W HagenA Neil Crowson
Jun 7, 2013·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Constantin A DasanuJonessa A Atienza
Dec 22, 2012·Dermatology : International Journal for Clinical and Investigative Dermatology·Ji-Hye ParkEun-Mi Koh
May 17, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lukas MarcelisThomas Tousseyn
Dec 2, 2008·Clinical and Experimental Dermatology·B F Chong, H K Wong
Feb 5, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Marc BeyerWolfram Sterry
Feb 5, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·S LourariC Paul
Oct 23, 2009·Dermatologic Therapy·Erica Dommasch, Joel M Gelfand
Jul 16, 2010·Photodermatology, Photoimmunology & Photomedicine·Laura Y McGirtEric C Vonderheid
Jul 21, 2005·The British Journal of Dermatology·S DalleL Thomas
Dec 20, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·G BiondoC Massone
Jun 15, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Hélène ThéophileBernard Bégaud
Jul 13, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·Christopher E M Griffiths, Giampiero Girolomoni
Nov 22, 2020·Clinical Journal of Gastroenterology·Takeshi YasudaYoshito Itoh
Dec 12, 2020·Journal of the American Academy of Dermatology·Michael J MurphyWilliam Damsky
Jun 1, 2021·Frontiers in Immunology·Violetta S GogolevaSergei A Nedospasov
Jul 25, 2009·Journal of the American Academy of Dermatology·Aikaterini-Evaggelia MoustouAlexander J Stratigos

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis